Brief: Innovate Biopharmaceuticals Appoints Ed Sitar as Chief Financial Officer
June 24 (Reuters) - Innovate Biopharmaceuticals Inc
INNT.O :
* INNOVATE BIOPHARMACEUTICALS EXPANDS ITS MANAGEMENT TEAM
WITH THE
ADDITION OF ED SITAR AS ITS CHIEF FINANCIAL OFFICER
* INNOVATE BIOPHARMACEUTICALS INC - ANNOUNCED APPOINTMENT OF
ED
SITAR AS ITS CHIEF FINANCIAL OFFICER COMMENCING ON JULY 1, 2019
Source text for Eikon: ID:nGNXbHVBV9
Further company coverage: INNT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on 9 Meters Biopharma
See all newsIllumina cuts annual profit forecast as biotech funding woes linger (updated)
Illumina cuts annual profit forecast
U.S. STOCKS ON THE MOVE-Pieris Pharma, Microsoft, Energy sector
U.S. STOCKS ON THE MOVE-Medtronic, Morgan Stanley, Bank of America
9 Meters Biopharma falls after filing for bankruptcy protection